Lassogen, Inc.
San Diego, USA
|
Description:
Lassogen is developing a new therapeutic modality based on lasso peptides that they are programming to treat difficult diseases such as cancer and autoimmune disorders. Lasso peptides are naturally produced by bacteria and represent a unique, vast, untapped source of novel molecular diversity for drug discovery and development. Lasso peptides also display an increasingly wide range of mechanisms of action, such as intracellular enzyme inhibition, extracellular protein binding, biosynthesis intermediate...
Lassogen is developing a new therapeutic modality based on lasso peptides that they are programming to treat difficult diseases such as cancer and autoimmune disorders. Lasso peptides are naturally produced by bacteria and represent a unique, vast, untapped source of novel molecular diversity for drug discovery and development. Lasso peptides also display an increasingly wide range of mechanisms of action, such as intracellular enzyme inhibition, extracellular protein binding, biosynthesis intermediate...